StreetInsider.com News Articles

Form 3 Seer, Inc. For: Oct 01 Filed by: Endweiss Charles

Thu, 08 Oct 2026 17:40:00 -0400

si-local-file:///var/storage/secattach/20261008/27167812.html

Seer and NTU to present early PRECISE-SG100K findings at HUPO

Wed, 23 Sep 2026 07:02:45 -0400

Seer, Inc. (Nasdaq: SEER) announced that researchers from Nanyang Technological University (NTU) will present early findings from the PRECISE-SG100K proteomics study at the 2026 Human Proteome Organization (HUPO) World Congress, running September 27 through October 1 at the Suntec Singapore Convention & Exhibition Centre.

The PRECISE-SG100K study integrates proteomic, genomic, clinical, and phenotypic data from Singapore's multi-ethnic population. A 10,000-participant component of the study uses Seer's Proteograph Product Suite combined with Thermo Scientific Orbitrap Astral mass spectrometry to profile the circulating proteome. Seer announced the selection of its Proteograph Product Suite for this component in April 2026.

John Chambers, PhD, Chief Scientific

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026

Wed, 23 Sep 2026 07:00:00 -0400

John Chambers, PhD, and Nilanjana Sadhu, PhD, to share early insights from pioneering population-scale proteomic study of 10,000 participants in Singapore

REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) today announced that researchers from Nanyang Technological University will present early findings from the PRECISE-SG100K study at the 2026 Human Proteome Organization (HUPO) World Congress, taking place September 27 to October 1 at the Suntec Singapore Convention & Exhibition Centre.

Led by John Chambers, PhD, Chief Scientific Officer of PRECISE and Lead PI of PRECISE-SG100K, the study represents an ambitious effort to bring

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026

Wed, 23 Sep 2026 07:00:00 -0400

John Chambers, PhD, and Nilanjana Sadhu, PhD, to share early insights from pioneering population-scale proteomic study of 10,000 participants in Singapore

Led by John Chambers, PhD, Chief Scientific Officer of PRECISE and Lead PI of PRECISE-SG100K, the study represents an ambitious effort to bring

Seer, Inc. CFO David Horn to depart, Charles Endweiss to step in

Mon, 21 Sep 2026 07:00:21 -0400

Seer, Inc. (Nasdaq: SEER) announced that David Horn, the company's President, Chief Financial Officer and Treasurer, will leave the company on October 1, 2026, to join a private company.

Charles Endweiss, who has served as Seer's Vice President of Financial Planning & Analysis since January 2021, will assume the roles of Treasurer, principal financial officer and principal accounting officer effective the same date.

Horn joined Seer more than six years ago. Endweiss, 49, previously served as Head of Business Operations, Oral Health at Carbon from August 2017 to January 2021. He holds a B.A. in Business from the University of Illinois, Urbana-Champaign

Seer Announces CFO Transition

Mon, 21 Sep 2026 07:00:00 -0400

REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the Company’s President, Chief Financial Officer and Treasurer, will depart Seer effective October 1, 2026, to pursue a new opportunity at a private company.

Charles Endweiss, who has been Seer’s Vice President, Financial Planning & Analysis, will serve as Treasurer, principal financial officer and principal accounting officer, effective October 1, 2026.

“David has been an important member of Seer’s leadership team

Seer Announces CFO Transition

Mon, 21 Sep 2026 07:00:00 -0400

“David has been an important member of Seer’s leadership team

Form 8-K Seer, Inc. For: Sep 14

Fri, 18 Sep 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260918/27080582.html

Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale

Wed, 16 Sep 2026 08:00:00 -0400

Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, disease biology and population health

REDWOOD CITY, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer in deep, unbiased proteomics, today announced that its Proteograph® Product Suite has been used by researchers in more than 100 peer-reviewed scientific publications, enabling researchers to uncover differentiated proteomic insights and marking a significant milestone in the emergence of deep proteomics at scale as a new paradigm for biological research.

Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale

Wed, 16 Sep 2026 08:00:00 -0400

Form 4 Seer, Inc. For: Aug 18 Filed by: Horn David R.

Thu, 27 Aug 2026 17:54:00 -0400

si-local-file:///var/storage/secattach/20260827/26991478.html

Form 4 Seer, Inc. For: Aug 18 Filed by: Horn David R.

Thu, 27 Aug 2026 17:54:00 -0400

si-local-file:///var/storage/secattach/20260827/26991478.html

Form 4 Seer, Inc. For: Aug 18 Filed by: Horn David R.

Wed, 19 Aug 2026 18:59:00 -0400

si-local-file:///var/storage/secattach/20260819/26951502.html

Form 4 Seer, Inc. For: Aug 18 Filed by: Horn David R.

Wed, 19 Aug 2026 18:59:00 -0400

si-local-file:///var/storage/secattach/20260819/26951502.html

Activist investors push Seer, Inc. to disclose go-private timeline

Thu, 13 Aug 2026 13:00:40 -0400

A shareholder group holding approximately 7.7% of Seer, Inc. (NASDAQ: SEER) issued an open letter to the company's board of directors, pressing it to publicly acknowledge that Seer should be taken private and to disclose a timeline for evaluating the latest acquisition proposals.

Bradley L. Radoff and Michael Torok, operating as the Radoff-JEC Group, submitted their fourth offer on July 28, 2026, proposing to acquire 100% of Seer's equity at $2.55 per share in cash, a price they describe as representing a 51% premium to the company's unaffected share price and a 16% premium to the share price as of August

Activist investors push Seer, Inc. to disclose go-private timeline

Thu, 13 Aug 2026 13:00:40 -0400

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

Thu, 13 Aug 2026 13:00:00 -0400

Believes Special Committee Is Not Truly Interested in Running a Robust Auction Based on its Tepid Engagement to Date

Continues to Believe – Consistent with Chairman and CEO Omid Farokhzad – Seer Should Not Remain a Public Company Given its Lack of a Credible Plan to Create Value for Stockholders and Q2 2026 Earnings, Which Reflected Lower Sales, Lower Gross Profit and Shrinking Cash Reserves

HOUSTON--(BUSINESS WIRE)-- Bradley L. Radoff and Michael Torok, who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (the “Company”), today issued the following open letter to the

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

Thu, 13 Aug 2026 13:00:00 -0400

Believes Special Committee Is Not Truly Interested in Running a Robust Auction Based on its Tepid Engagement to Date

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

Thu, 13 Aug 2026 13:00:00 -0400

Believes Special Committee Is Not Truly Interested in Running a Robust Auction Based on its Tepid Engagement to Date

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

Thu, 13 Aug 2026 13:00:00 -0400

Believes Special Committee Is Not Truly Interested in Running a Robust Auction Based on its Tepid Engagement to Date

Seer, Inc. (SEER) Misses Q2 EPS by 9c

Tue, 11 Aug 2026 16:50:59 -0400

Seer, Inc. (NASDAQ: SEER) reported Q2 EPS of ($0.31), $0.09 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Seer, Inc. (SEER) click here.

Form 10-Q Seer, Inc. For: Jun 30

Tue, 11 Aug 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260811/26906583.html

Form 10-Q Seer, Inc. For: Jun 30

Tue, 11 Aug 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260811/26906583.html

Form 8-K Seer, Inc. For: Aug 11

Tue, 11 Aug 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260811/26906160.html

Form 8-K Seer, Inc. For: Aug 11

Tue, 11 Aug 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260811/26906160.html